Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last ¥3,045 JPY
Change Today -45.00 / -1.46%
Volume 1.1M
4543 On Other Exchanges
As of 2:00 AM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

terumo corp (4543) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/19/15 - ¥3,445
52 Week Low
05/7/14 - ¥1,954
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TERUMO CORP (4543)

Related News

No related news articles were found.

terumo corp (4543) Related Businessweek News

No Related Businessweek News Found

terumo corp (4543) Details

Terumo Corporation manufactures and sells medical products and equipment worldwide. The company operates through Cardiac & Vascular, General Hospital, and Blood Management segments. Its cardiac and vascular products primarily comprise interventional devices that include access devices, such as introducer sheaths, guidewires, and guiding catheters; therapeutic devices, which include balloon catheters and stents; intravascular imaging systems; and cardiopulmonary bypass systems comprising oxygenator with integrated arterial filters, heart-lung machines, and artificial thoracic vascular grafts. The company’s general hospital products principally include infusion systems, including infusion pumps, infusion solutions, IV catheter, and infusion line connectors; drug and devices comprising prefilled syringes and prefillable syringes; nutritional supplements; measuring devices systems with communication functions, such as blood glucose meters, blood pressure monitors, and thermometers; pain management medicines that include analgesic and antiemetic; and closed anticancer drug infusion systems. Its blood management products primarily comprise automated blood collection systems, blood bag systems with leukocyte reduction filters, automated blood component processing system, pathogen reduction technology systems, therapeutic apheresis systems, and cell expansion systems. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was founded in 1921 and is headquartered in Tokyo, Japan.

19,263 Employees
Last Reported Date: 06/25/14
Founded in 1921

terumo corp (4543) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

terumo corp (4543) Key Developments

Terumo Corporation Concludes Basic Agreement with Olympus Corporation to Expand Business Partnership Covering Medical Interventional System Products in the United States

Terumo Corporation announced that it has concluded a basic agreement with Olympus Corporation to expand their business partnership covering medical interventional system products in the United States. With this move, both companies will, for the first time, jointly market products in the field of Urology in the U.S., as well as explore opportunities to broaden the types of products offered in the field of Gastroenterology, which is already an established area of focus of the partnership. The objective of the expanded partnership is to achieve business growth in the U.S., by leveraging the competitive advantages of both companies. The partnership joins the guidewire brand with the endoscope brand. Olympus and Terumo have jointly developed a guidewire since 2009, which is designed for guiding minimally invasive treatment devices during biliary endoscopy procedures. Through the partnership, Terumo will benefit from the U.S. presence and marketing arm of Olympus in the Urology and Gastroenterology spaces, and Olympus will broaden its assortment of guidewires from Terumo. Terumo’s guidewire has gained widespread endorsements in the U.S. as a diagnostic and intravascular treatment tool. The research and development efforts through the partnership will be aligned toward improving quality of care and advancing minimally invasive procedures. Guidewires produced by Terumo will be supplied by Terumo’s U.S. subsidiary, Terumo Medical Corporation, for Olympus’s U.S. subsidiary, Olympus America Inc. Plans are in place for Olympus America Inc. to distribute—to the US market—Terumo’s urologic products beginning this May and biliary products later in 2015. Terumo also intends to continue separately marketing its interventional system products in the fields of cardiology, peripheral artery disease, and neurovascular disease in the United States.

Terumo Corporation Presents at Mizuho New York Healthcare Conference 2015, Mar-02-2015

Terumo Corporation Presents at Mizuho New York Healthcare Conference 2015, Mar-02-2015 . Venue: Omni Berkshire Place, 21 East 52nd Street at Madison Ave, New York, NY 10022, United States. Speakers: Kazuaki Kitabatake, Senior Executive Officer.

Terumo Corporation to Establish New R&D Center in Southern California

Terumo Corporation has announced that it will establish an R&D center in Southern California to reportedly enhance its R&D capability of the coronary and peripheral interventional therapeutic area. Terumo will invest approximately JPY 10 billion to the center and is intending to start the operation in fiscal year 2017. Terumo has decided to build the new R&D center for the development of cutting-edge interventional systems products by leveraging MicroVention's capability and networking resources in a technology area. The facility will also drive forward neurovascular device development lead by MicroVention.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4543:JP ¥3,045.00 JPY -45.00

4543 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CR Bard Inc $170.94 USD +1.38
Edwards Lifesciences Corp $127.75 USD +0.56
Hospira Inc $87.73 USD +0.44
Olympus Corp ¥4,320 JPY -20.00
Teleflex Inc $124.61 USD +2.00
View Industry Companies

Industry Analysis


Industry Average

Valuation 4543 Industry Range
Price/Earnings 37.8x
Price/Sales 2.4x
Price/Book 2.0x
Price/Cash Flow 37.6x
TEV/Sales 1.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TERUMO CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at